Toronto, Canada, June 13, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD”), a federally-licensed producer and distributor of medical cannabis, and Revive Therapeutics Ltd. (TSX-V:RVV) (OTCQB:RVVTF) (FSE:31R) (“Revive”), a company focused on the research, development and commercialization of novel cannabinoid-based therapies, are pleased to announce...
Toronto, Canada, June 11, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has secured its Health Canada Cultivation Licence for the first four grow rooms within its 220,000 sq. ft....
Toronto, Canada, May 31, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, has reported its financial and operating results for the first quarter ending March 31, 2018. WeedMD is pleased to report revenues of $1.14 million...
Toronto, Canada, May 1, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, has announced its financial results for the fourth quarter and fiscal year ending December 31, 2017. WeedMD is pleased to report revenue of $1.4...
Introducing Josephine DesLauriers. She joined our team recently as the Vice President of People and her role will be integral as we scale for growth, amplify our recruitment drive and prepare for our pending merger with Hiku Brands. Josephine brings a refreshing outlook and strategic vision...
The Transaction combines a premium cannabis brand house and retail focused operator in Hiku, with the significant production capabilities and differentiated medical brand in WeedMD Vertically integrated operations secure control over the entire cannabis value chain Coast-to-coast and diversified cannabis cultivation platform with four...
Toronto, Canada, March 27, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that the Company has appointed Dr. Jonas Vanderzwan as Medical Director and Chair of its Clinical Advisory Board....
Toronto, Canada, March 21, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has made a strategic investment in Snipp Interactive Inc. (TSX-V:SPN) (“Snipp”), a global loyalty and promotions...
Toronto, Canada, March 19, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pleased to announce that it has made a strategic investment in Scorpion Resources Inc., to be...
Construction on Track and on Budget with First Harvest Expected in July 2018 Toronto, Canada, March 13, 2018 – WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”),...
To help ensure our patients are up to date with all procedures and measures being taken during this time, we have created a website specific to WeedMD and COVID-19 updates.
VISIT PAGE NOW